Medical Health & Life Science Research News

Research details developments in the migraine drug market

Medical Market Research

The Middle East and Africa Migraine Drug Market was worth USD 0.33 billion in 2016 and estimated to be growing at a CAGR of 5.098 %, to reach USD 0.42 billion by 2021.

Get research details now! Make an enquiry for a fast response. 

- Advertisement -

A few organizations, for example, the American Headache and Migraine Association are increasing awareness programs and are giving help to patients with a specific end goal to spread awareness about the illness and other cerebral pain related scatters.

Access Sample Report @…10/request-sample

Access report @…/request-discount

The expanding requirement for new treatment choices has prompted to the improvement of new devices, for example, ant migraine devices and headbands in the market. For example, Cefaly Transcutaneous Electrical Nerve Stimulation devices is a FDA affirmed devices for headache treatment.

Get research details now! Make an enquiry for a fast response. 

- Advertisement -

This device animates the trigeminal nerve by emanating electric streams and gives reduction from headache. Expanding spending in new research exercises and novel item advancements are relied upon to quicken the development and improvement of this market throughout the following four years.

Market can be segmented by Treatment and Therapeutic class.

By Treatment – Preventive and Absorptive

By Therapeutic class – triptants, ergots and others

Key players in the market are  Allergan, GlaxoSmithKline, Pfizer, Endo, Impax Laboratories.The other prominent vendors the market include AbbottAeriel BioPharma, Alder Biopharmaceuticals, Amgen, Astellas, Bayer, CoLucid, Eli Lilly, IntelGenx, Ethypharm,Johnson & Johnson, Kowa Pharmaceuticals America, Klaria, Luitpold Pharmaceuticals, AstraZeneca, Meda, Dr. Reddy's Laboratories,  OptiNose, Pfizer, Pozen, Eisai, Raptor, RedHill, SUDA, Teva, , Aegis Therapeutics, Merck, TG Therapeutics, NValeant, Winston Pharmaceuticals, Allergan,  and Zogenix.

News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...

For more information:

Make an Inquiry about this report HERE!